William F. Doyle
2018
In 2018, William F. Doyle earned a total compensation of $4.6M as Executive Chairman at NovoCure, a 81% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $843,750 |
---|---|
Option Awards | $2,359,400 |
Salary | $750,000 |
Stock Awards | $587,505 |
Other | $18,000 |
Total | $4,558,655 |
Doyle received $2.4M in option awards, accounting for 52% of the total pay in 2018.
Doyle also received $843.8K in non-equity incentive plan, $750K in salary, $587.5K in stock awards and $18K in other compensation.
Rankings
In 2018, William F. Doyle's compensation ranked 2,303rd out of 14,244 executives tracked by ExecPay. In other words, Doyle earned more than 83.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,303 | 84th |
Manufacturing | 843 | 85th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 99 | 88th |
Surgical, Medical, And Dental Instruments And Supplies | 47 | 91st |
Surgical and Medical Instruments and Apparatus | 25 | 93rd |
Doyle's colleagues
We found five more compensation records of executives who worked with William F. Doyle at NovoCure in 2018.